Drug intelligence / Profile preview

Yaotongning

Development stage
Unknown
Lead developer
Jingfukang Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Yaotongning is a Traditional Chinese Medicine (TCM) capsule developed and manufactured by Jingfukang Pharmaceutical Group. It is primarily indicated for the treatment of lumbar-related conditions, including lumbar disc herniation, lumbar osteoarthritis, sciatica, and rheumatoid arthritis. The formulation typically contains processed *Strychnos nux-vomica* (Ma Qian Zi) as a key active ingredient, along with other herbs like *Ephedra*, *Achyranthes bidentata*, and *Boswellia*. It is designed to dispel wind, remove dampness, activate blood circulation, and relieve pain. Clinical evaluations, including post-marketing studies registered in the Chinese Clinical Trial Registry (ChiCTR), have focused on its efficacy and safety in treating lumbar disc herniation and osteoarthritis compared to other TCM formulations like Bitongning or Yaobitong.

Brand names
YaotongningYaotongning Capsule
Other names
腰痛宁胶囊Yaotongning Jiaonang
02

Targets

COXGlycine receptorAR (Adrenergic receptors)

Beyond the preview

Go deeper on Yaotongning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaotongning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call